Shuttle Pharmaceuticals Holdings (SHPH) Treasury Shares (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Treasury Shares of $106891.0 in Q1 2026, down 29.52% quarter-over-quarter from $151657.0 in Q4 2025, and down 86.59% on a YoY basis from $796925.0 in Q1 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Treasury Shares (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Treasury Shares history runs 6 years deep, the most recent figure standing at $106891.0 for Q1 2026.
- In Q1 2026, Treasury Shares fell 86.59% year-over-year to $106891.0; the TTM figure through Mar 2026 stood at $106891.0 (down 86.59% YoY), while the FY2025 annual figure was $151657.0, up 249.55% from the prior year.
- Treasury Shares was $106891.0 for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from $151657.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $796925.0 in Q1 2025 to a low of $2966.0 in Q4 2022.
- Historically, Treasury Shares has averaged $123851.9 across 5 years, with a median of $51112.5 in 2024.
- The sharpest annual moves came in 2025 and 2026: Treasury Shares surged 2236.61% in 2025, then slumped 86.59% in 2026.
- A 5-year view of Treasury Shares shows it stood at $2966.0 in 2022, then jumped by 733.82% to $24731.0 in 2023, then soared by 75.43% to $43386.0 in 2024, then jumped by 249.55% to $151657.0 in 2025, then retreated by 29.52% to $106891.0 in 2026.
- The last three Treasury Shares figures came in at $106891.0 (Q1 2026), $151657.0 (Q4 2025), and $166822.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 107.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 4.80 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 1.42 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 17.13 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 19.58 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 7.24 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 2.17 Mn | 1.11 Mn | - | 106,891.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106,891.00 |
| Mar 31, 2026 | 106,891.00 |
| Dec 31, 2025 | 151,657.00 |
| Dec 31, 2025 | 151,657.00 |
| Sep 30, 2025 | 166,822.00 |
| Sep 30, 2025 | 166,822.00 |
| Jun 30, 2025 | 31,442.00 |
| Jun 30, 2025 | 31,442.00 |
| Mar 31, 2025 | 796,925.00 |
| Mar 31, 2025 | 796,925.00 |
| Dec 31, 2024 | 43,386.00 |
| Dec 31, 2024 | 43,386.00 |
| Sep 30, 2024 | 41,338.00 |
| Sep 30, 2024 | 41,338.00 |
| Jun 30, 2024 | 58,839.00 |
| Jun 30, 2024 | 58,839.00 |
| Mar 31, 2024 | 34,106.00 |
| Mar 31, 2024 | 34,106.00 |
| Dec 31, 2023 | 24,731.00 |
| Dec 31, 2023 | 24,731.00 |